Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Insulet Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
Prev close 139.28 · gapped below the open, then crossed back over prior close. High/low 140.21 at 6:45 am ET, 136.80 at 9:45 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Distributor A 28 % 28 % 19 %”
$758M relationship
basisPODD fy2025 · closed 2025-12 $2.7B
FILING10-K0001145197-25-000007cik 0001145197
“Distributor B 26 % 24 % 16 %”
$704M relationship
basisPODD fy2025 · closed 2025-12 $2.7B
FILING10-K0001145197-25-000007cik 0001145197
“Distributor C 21 % 19 % 17 %”
$569M relationship
basisPODD fy2025 · closed 2025-12 $2.7B
FILING10-K0001145197-25-000007cik 0001145197
“We have received our ISO, European Union MDR, and Medical Device Single Audit Program certifications for our Quality Management System from BSI Group, an accredited Notified Body for CE Marking.”
FILING10-K0001145197-25-000007cik 0001145197
“Substantially all of the Company's Drug Delivery revenue consists of sales of pods to Amgen for use in the Neulasta ® Onpro ® kit, a delivery system for Amgen's Neulasta to help reduce the risk of infection after intense chemotherapy.”
FILING10-K0001145197-25-000007cik 0001145197
“In February 2023, the Company paid Bigfoot Biomedical, Inc. $ 25.1 million, including transaction costs, to acquire patent assets related to pump-based automated insulin delivery technologies.”
FILING10-K0001145197-25-000007cik 0001145197
“On January 3, 2022, the Company acquired substantially all of the assets related to the manufacture and production of shape-memory alloy wire assemblies that are used in the production of Pods from Dynalloy, Inc., a maker of dynamic alloys.”
FILING10-K0001145197-25-000007cik 0001145197
“We have partnered with Glooko Inc. ("Glooko") to connect user data with Glooko's comprehensive diabetes data management system (including Glooko and Diasend in selected regions).”
FILING10-K0001145197-25-000007cik 0001145197
“10.64++ Purchase Agreement by and between Insulet Corporation and NXP USA, Inc., dated October 12, 2017 (Incorporated by reference to Exhibit 10.59 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed February 23, 2024).”
FILING10-K0001145197-25-000007cik 0001145197
“10.53++ Materials Supplier Agreement between Insulet Corporation and Sanmina Corporation, dated October 11, 2018. (Incorporated by reference to Exhibit 10.43 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed February 24, 2022)”
FILING10-K0001145197-25-000007cik 0001145197
“We have partnered with Glooko Inc. ("Glooko") to connect user data with Glooko's comprehensive diabetes data management system (including Glooko and Diasend in selected regions).”
FILING10-K0001145197-25-000007cik 0001145197
“The Pod currently integrates with Dexcom, Inc.'s G6 and G7 CGMs and with Abbott Diabetes Care, Inc.'s ("Abbott") FreeStyle Libre 2 Plus sensor ("Libre 2 Plus") in various markets.”
FILING10-K0001145197-26-000028cik 0001145197
“The Pod currently integrates with Dexcom, Inc.'s G6 and G7 CGMs and with Abbott Diabetes Care, Inc.'s ("Abbott") FreeStyle Libre 2 Plus sensor ("Libre 2 Plus") in various markets.”
FILING10-K0001145197-26-000028cik 0001145197
“10.67+ Master Equipment and Services Agreement between Insulet Corporation and ATS Automated Tooling Systems Inc., dated August 31, 2016 (Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016, filed November 4, 2016)”
FILING10-K0001145197-25-000007cik 0001145197
“The Pod currently integrates with Dexcom, Inc.'s G6 and G7 CGMs and with Abbott Diabetes Care, Inc.'s ("Abbott") FreeStyle Libre 2 Plus sensor ("Libre 2 Plus") in various markets.”
FILING10-K0001145197-26-000028cik 0001145197
“The Pod currently integrates with Dexcom, Inc.'s G6 and G7 CGMs and with Abbott Diabetes Care, Inc.'s ("Abbott") FreeStyle Libre 2 Plus sensor ("Libre 2 Plus") in various markets.”
FILING10-K0001145197-26-000028cik 0001145197
Watchlist prices, news filtered to it, and its next report on your desk.
Insulet Corp has 10 disclosed suppliers and 6 disclosed customers. Each one is named in an SEC filing, either Insulet Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
PODD (Insulet Corp) has 10 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SANM −2.68%, in semiconductor.